Viva Star Biosciences Overview
- Founded
- 2021
- Status
- Private
- Latest Deal Type
- Series A
- Investors
- 4
Viva Star Biosciences General Information
Description
Developer of age-related debilitating disease therapy. The company focuses on the discovery and development of therapy around debilitating diseases caused by inflammation and tissue fibrosis.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Primary Office
- Unit 207, Building A4, Phase I Project, Biomedical Industrial Park, No. 218, Xinghu Street
- Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone
- Suzhou, Jiangsu
- China
Viva Star Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 06-Jan-2022 | Completed | Startup |
Viva Star Biosciences Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Hongjian Zhang | Chairman & General Manager |
Viva Star Biosciences Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hongjian Zhang | Viva Star Biosciences | Chairman & General Manager | 000 0000 |
Viva Star Biosciences Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 5Y Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Firstred Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Ming Bioventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Yonghua Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |